D7001ZZ
Beam Radiation Bone Marrow to None with None, Photons 1 - 10 MeV Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | D Radiation Therapy |
| Body System | 7 Lymphatic and Hematologic System |
| Operation | 0 Beam Radiation |
| Body Part | 0 Bone Marrow |
| Approach | 1 Photons 1 - 10 MeV |
| Device | Z None |
| Qualifier | Z None |
Procedure Overview
Beam radiation to the lymphatic and hematologic system delivers external radiation, typically from a linear accelerator, to lymph node regions or hematologic tissue affected by cancers such as Hodgkin lymphoma, non-Hodgkin lymphoma, or localized involvement from leukemia. Treatment is usually planned as a fractionated course given over several weeks, with the total dose divided into smaller daily sessions to maximize tumor control while allowing normal tissue to recover between treatments.
It is used both as primary therapy for certain lymphomas confined to specific nodal regions and as consolidation after chemotherapy to eliminate residual disease in previously bulky sites. Patients typically receive planning imaging beforehand to map the treatment field precisely to the involved nodal chain.
Anatomy & Axis Detail
Bone Marrow
Bone marrow, the soft tissue filling the medullary cavities of bones, is the site of hematopoiesis and a common target when malignant or abnormal blood-forming cells must be suppressed across a broad marrow field, as in preparation for hematopoietic stem cell transplantation or in treating diffuse marrow involvement by leukemia. Because functioning marrow is distributed throughout the axial and sometimes appendicular skeleton, beam radiation here is typically delivered as total body or total marrow irradiation, requiring careful planning to spare adjacent organs such as the lungs, liver, and kidneys while achieving myeloablation or cytoreduction. The marrow's radiosensitivity means even modest doses produce profound, expected cytopenias, and documentation should reflect the intended broad field rather than treatment aimed at a single localized lesion.
Modality Qualifier: Photons 1 - 10 MeV
Photons 1 to 10 MeV identifies radiation therapy delivered using megavoltage photon beams in this energy range, the standard produced by most modern linear accelerators for treating deeper tumors with better skin sparing and dose distribution than lower-energy beams. It is distinguished from the sub-1 MeV range used for superficial treatment and represents the energy band applied to the majority of external beam courses.
Coding & Documentation
Coders need documentation specifying the treatment site (a named lymph node region, spleen, or other hematologic structure), the modality as external beam, and the qualifier describing the type of beam, such as photon or electron therapy, drawn from the radiation oncology treatment plan and daily treatment records.
A common error is coding the diagnosis-driven anatomic site rather than the actual field treated, since radiation fields are often described in oncology shorthand like "mantle field" or "involved-site radiotherapy" that must be translated to the correct body part value. Failing to capture the correct qualifier for beam type is another frequent gap when the treatment summary isn't reviewed closely.